Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

279 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Emotional dysregulation in adult ADHD and response to atomoxetine.
Reimherr FW, Marchant BK, Strong RE, Hedges DW, Adler L, Spencer TJ, West SA, Soni P. Reimherr FW, et al. Among authors: west sa. Biol Psychiatry. 2005 Jul 15;58(2):125-31. doi: 10.1016/j.biopsych.2005.04.040. Biol Psychiatry. 2005. PMID: 16038683 Clinical Trial.
Atomoxetine in adults with ADHD: two randomized, placebo-controlled studies.
Michelson D, Adler L, Spencer T, Reimherr FW, West SA, Allen AJ, Kelsey D, Wernicke J, Dietrich A, Milton D. Michelson D, et al. Among authors: west sa. Biol Psychiatry. 2003 Jan 15;53(2):112-20. doi: 10.1016/s0006-3223(02)01671-2. Biol Psychiatry. 2003. PMID: 12547466 Clinical Trial.
Changes in symptoms and adverse events after discontinuation of atomoxetine in children and adults with attention deficit/hyperactivity disorder: a prospective, placebo-controlled assessment.
Wernicke JF, Adler L, Spencer T, West SA, Allen AJ, Heiligenstein J, Milton D, Ruff D, Brown WJ, Kelsey D, Michelson D. Wernicke JF, et al. Among authors: west sa. J Clin Psychopharmacol. 2004 Feb;24(1):30-5. doi: 10.1097/01.jcp.0000104907.75206.c2. J Clin Psychopharmacol. 2004. PMID: 14709944 Clinical Trial.
Once-daily atomoxetine treatment for children and adolescents with attention deficit hyperactivity disorder: a randomized, placebo-controlled study.
Michelson D, Allen AJ, Busner J, Casat C, Dunn D, Kratochvil C, Newcorn J, Sallee FR, Sangal RB, Saylor K, West S, Kelsey D, Wernicke J, Trapp NJ, Harder D. Michelson D, et al. Am J Psychiatry. 2002 Nov;159(11):1896-901. doi: 10.1176/appi.ajp.159.11.1896. Am J Psychiatry. 2002. PMID: 12411225 Clinical Trial.
279 results